degenerative disc disease ddd epidemiology forecast

Degenerative Disc Disease (DDD) Insights and Trends

• According to DelveInsight’s analysis, the total diagnosed prevalent cases of DDD were ~ 28 million in the 7MM (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
• DDD is a chronic musculoskeletal condition characterized by progressive degeneration of intervertebral discs, leading to chronic back pain, reduced mobility, and functional impairment. The condition is increasingly prevalent due to aging populations, sedentary lifestyles, obesity, and rising spinal disorders globally. DDD commonly affects the lumbar and cervical spine, with lumbar DDD accounting for a larger disease burden due to its high association with lower back pain and disability.
• Across the 7MM, nearly 8 million patients are estimated to have moderate-to-severe DDD, highlighting a substantial clinical burden and significant demand for effective long-term treatment options.
• Women experience accelerated post-menopausal disc degeneration linked to estrogen-dependent proteoglycan decline; however, sex-specific disease progression remains significantly underrepresented in current treatment guidelines and clinical trial stratification.
• MRI (Magnetic Resonance Imaging) remains the diagnostic gold standard due to superior visualization of annular tears, modic changes, nerve compression, and hydration loss; nevertheless, its low specificity for pain generation contributes to substantial overdiagnosis and potentially avoidable interventions. Discography continues to be used selectively for surgical planning despite evidence suggesting that the procedure itself may accelerate disc degeneration, creating a clinically controversial iatrogenic paradox.
• Increasing aging populations, sedentary lifestyles, obesity rates, and rising incidence of spinal disorders are expected to drive the burden of DDD over the coming decade. Advances in understanding disc degeneration mechanisms, early diagnosis, and the development of regenerative and targeted therapies will be critical in improving future disease management and patient outcomes.

Degenerative Disc Disease (DDD) Epidemiology Forecast in 7MM

• 2025 Diagnosed Prevalent Cases of DDD: ~ 28 million
• 2036 Projected Diagnosed Prevalent Cases of DDD: XX million
• DDD Growth Rate (2026–2036): XX% CAGR

DelveInsight's ‘Degenerative Disc Disease (DDD)– Epidemiology Forecast – 2036’ report delivers an in-depth understanding of the DDD, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan.

Degenerative Disc Disease (DDD) Understanding and Diagnosis Algorithm

DDD is a progressive spinal condition characterized by the gradual breakdown of intervertebral discs, which act as cushions between the vertebrae. It commonly occurs due to age-related wear and tear, leading to loss of disc hydration, elasticity, and structural integrity. As the discs deteriorate, patients may experience chronic neck or lower back pain, stiffness, reduced flexibility, and pain radiating to the arms or legs due to nerve compression. In advanced stages, DDD can contribute to disc herniation, spinal instability, or osteoarthritis of the spine. The condition is primarily caused by aging, repetitive mechanical stress, obesity, spinal injuries, poor posture, and genetic predisposition.

DDD is diagnosed through clinical evaluation and imaging tests in patients with chronic back or neck pain. Physical examination assesses pain, mobility, and neurological function, while X-rays, MRI, or CT scans help identify disc degeneration, nerve compression, and spinal abnormalities. In some cases, nerve conduction studies or EMG may also be performed.

Note: Further details are provided in the report.

Degenerative Disc Disease (DDD) Epidemiology

Key Findings from DDD Epidemiological Analysis and Forecast

• According to DelveInsight’s estimates, the total number of diagnosed prevalent cases of DDD in the 7MM was nearly 28 million cases in 2025 and is projected to increase during the forecasted period.
• The total number of diagnosed prevalent cases of DDD in the United States was nearly 14 million in 2025.
• Among the EU4, France accounted for the highest number of diagnosed prevalent cases of DDD, followed by Germany, whereas Spain accounted for the lowest number of cases in 2025.
• In 2025, DDD predominantly affected females in the United States, with 7,951,082 cases, while the male population accounted for 6,282,074 cases. By 2036, these numbers are expected to rise to 8,933,829 cases in females and 7,058,533 cases in males.
• In the US, approximately 30.8% of prevalent DDD cases in 2025 were observed in individuals aged below 60 years, while around 69.2% of cases were reported in the population aged 60 years and above.

Scope of the Report

• The report covers a segment of an executive summary, a descriptive overview of DDD, explaining its causes, signs and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

• DDD patient population forecast

Report Key Strengths

• Epidemiology-based (epi-based) bottom-up forecasting
• 11-year forecast
• Patient burden trends (by geography)

FAQs

• What are the disease risks, burdens, and unmet needs of DDD? What will be the growth opportunities across the 7MM concerning the patient population with DDD?
• What is the historical and forecasted DDD patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders’ perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.